Literature DB >> 10575308

Mizoribine for childhood IgA nephropathy.

K Kaneko, R Nagaoka, Y Ohtomo, Y Yamashiro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10575308     DOI： 10.1159/000045438

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  8 in total

1.  Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.

Authors:  Shuichiro Fujinaga; Kazunari Kaneko; Yoshiyuki Ohtomo; Hitohiko Murakami; Masaru Takada; Shunji Akashi; Mayako Hira; Yuichiro Yamashiro
Journal:  Pediatr Nephrol       Date:  2005-07-15       Impact factor: 3.714

2.  Fanconi syndrome in an elderly patient with membranous nephropathy during treatment with the immunosuppressant mizoribine.

Authors:  Sho Nishikawa; Naoki Takahashi; Yudai Nishikawa; Seiji Yokoi; Sayu Morita; Yuki Shimamoto; Sayumi Sakashita; Kazuhisa Nishimori; Mamiko Kobayashi; Sachiko Fukushima; Daisuke Mikami; Hideki Kimura; Kenji Kasuno; Hironobu Naiki; Masayuki Iwano
Journal:  CEN Case Rep       Date:  2022-06-24

3.  Safety and efficacy of mizoribine in patients with connective tissue diseases other than rheumatoid arthritis.

Authors:  Ryo Rokutanda; Mitsumasa Kishimoto; Sachiko Ohde; Hisanori Shimizu; Atsushi Nomura; Yasuhiro Suyama; Yuri Ohara; Kenichi Yamaguchi; Masato Okada
Journal:  Rheumatol Int       Date:  2013-01-03       Impact factor: 2.631

4.  Mizoribine is as Effective as Methotrexate for the Treatment of Polymyalgia Rheumatica: A Retrospective Case Series Analysis.

Authors:  Kazushige Shiraishi; Masei Suda; Ryo Rokutanda; Mitsumasa Kishimoto; Masato Okada
Journal:  Arch Rheumatol       Date:  2018-01-15       Impact factor: 1.472

5.  The Efficacy of Mizoribine (Inosine Monophosphate Dehydrogenase Inhibitor) for ANCA-Associated Vasculitis with Hepatitis B Virus Carrier.

Authors:  Jun Muratsu; Atsuyuki Morishima; Masayoshi Kukida; Anzu Tanaka; Shigeki Fujita; Katsuhiko Sakaguchi
Journal:  Case Reports Immunol       Date:  2012-12-11

6.  Mizoribine Synchronized Methotrexate Therapy should be Considered when Treating Rheumatoid Arthritis Patients with an Inadequate Response to Various Combination Therapies.

Authors:  Keigo Ikeda; Kozo Watanabe; Takuya Hirai; Kana Tanji; Tomoko Miyashita; Shihoko Nakajima; Kaori Uomori; Shinji Morimoto; Kenji Takamori; Hideoki Ogawa; Yoshinari Takasaki; Iwao Sekigawa
Journal:  Intern Med       Date:  2017-05-15       Impact factor: 1.271

7.  Mizoribine as a safe and effective combined maintenance therapy with prednisolone for anti-neutrophil cytoplasmic antibody-associated vasculitis in a hemodialysis patient.

Authors:  Gen Nakamura; Noriyuki Homma; Yuichi Sakamaki; Mio Toyama; Megumi Unno; Takeshi Kuroda; Ichiei Narita
Journal:  CEN Case Rep       Date:  2013-01-30

Review 8.  Mizoribine: a new approach in the treatment of renal disease.

Authors:  Yukihiko Kawasaki
Journal:  Clin Dev Immunol       Date:  2009-12-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.